Jubilant Pharmova has completed acquisition of 19.89% stake in O2 Renewable Energy XVI (O2) i.e. 75,903 Compulsory Convertible Debentures (CCDs) of face value of Rs 1,000 each and 8,43,362 Equity shares of face value of Rs 10 each. On March 29, 2024, the company had acquired 64,517 CCDs and 7,16,857 equity shares in O2.
Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.